In Depth 19 Mar 2025
Breast cancer treatments heat up: Five therapies poised to transform patient outcomes
Find out more about the overall breast cancer treatment landscape, as biotech companies make progress with different approaches.
- Latest Posts
Best in Biotech 18 Mar 2025
Cancer vaccines: 11 biotechs to keep an eye out for
As various biotechs across the world specialize in the production of cancer vaccines, here are 11 companies making progress in the field.
In Depth 17 Mar 2025
How biotechs are using AI to rescue failed drugs
Discover how biotech companies like Ignota Labs and BioXcel Therapeutics are using AI to rescue failed drugs.
In Depth 14 Mar 2025
Can GLP-1 agonists help treat addiction?
Discover how researchers have been exploring the potential of GLP-1 drugs for treating addiction disorders.
Podcast 14 Mar 2025
Fighting Alzheimer’s with innovative stem cell therapies
This week, we talk with Christopher Duma about his career in neurosurgery, the impetus for launching his biotech, and the promise of stem cell therapy in Alzheimer’s.
Best in Biotech 13 Mar 2025
Nine biotechs thriving in Seattle in 2025
In this article, let us take a look at some of the major biotech companies in Seattle that are contributing to the biotech industry at large.
ADVERTISEMENT
ADVERTISEMENT
In Depth 12 Mar 2025
Checkpoint inhibitors in cancer: breakthroughs, setbacks, and what’s next
Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.
In Depth 11 Mar 2025
The gender gap in clinical trials: Why women are still underrepresented
Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is correcting it.
News and Trends 10 Mar 2025
23andMe: the collapse of a genomics giant
23andMe was once worth $6 billion and is now a penny stock. Layoffs, data breaches, and mass resignations plagued the genomics giant. How did it all unfold?
In Depth 7 Mar 2025
Catalonia: A biotech hub going from strength to strength, with Barcelona at its core
Take a deeper look at Catalonia’s biotech sector and overall life sciences hub, including the key drivers behind its success.
Podcast 7 Mar 2025
[Rebroadcast] How AI immune system mapping can boost drug discovery
Learn about the data gap in drug discovery and how machine learning (ML) can solve it in our talk with Noam Solomon, CEO and co-founder of Immunai.
News and Trends 6 Mar 2025
Top biotech deals of February 2025
Find out about the top biotech partnership deal of February 2025. Small molecules, T-cell engagers, and RNA medicines, were all part of major collaborations.
ADVERTISEMENT
